Over recent times,
MetLife, Inc. (MET) faced regulatory attention, settling over Iran sanctions violations. Notably,
Victory Capital Management and
Cornercap Investment Counsel proceeded to sell MET shares. However, MetLife's reputation remains robust, highlighted in it being recognized among
Fortune’s Top 25 Global Workplaces. Despite shifts in the market, metLife aims to balance
premiums and investment income. Meanwhile, both institutional and retail investors showed varying degrees of interest, such as
OVERSEA CHINESE BANKING Corp Ltd investing $931,000 and
Kovack Advisors Inc. acquiring 13,326 MET shares. Critics questioned MetLife's Q3 earnings, considering both
revenue and EPS, but MetLife continues to be seen as a solid
dividend stock. MetLife's diversification efforts included joining forces with the
Human Animal Bond Research Institute. Reports have emerged of potential talks for MetLife to acquire ex-China assets of
PineBridge for $1 bln-$1.5 bln. Investors saw a
121% increase over the last five years, despite some arguing the recent weakness in the group
benefits business and elevated costs.
Metlife MET News Analytics from Thu, 21 Mar 2024 07:00:00 GMT to Sat, 16 Nov 2024 10:39:54 GMT -
Rating 7
- Innovation 3
- Information 8
- Rumor -6
